Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ZBTB7A Antikörper (N-Term)

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch ZBTB7A in WB und IHC. Es zeigt Reaktivität gegenüber Proben von Maus und Ratte.
Produktnummer ABIN3044569
500,50 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für ZBTB7A Antikörper (N-Term) (ABIN3044569)

Target

Alle ZBTB7A Antikörper anzeigen
ZBTB7A (Zinc Finger and BTB Domain Containing 7A (ZBTB7A))

Reaktivität

  • 76
  • 32
  • 27
  • 10
  • 7
  • 6
  • 6
  • 4
  • 2
  • 2
  • 1
Maus, Ratte

Wirt

  • 86
  • 2
Kaninchen

Klonalität

  • 73
  • 15
Polyklonal

Konjugat

  • 33
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser ZBTB7A Antikörper ist unkonjugiert

Applikation

  • 63
  • 30
  • 19
  • 19
  • 18
  • 15
  • 14
  • 14
  • 14
  • 11
  • 4
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 28
    • 15
    • 8
    • 7
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Verwendungszweck

    Anti-ZBTB7A Antibody

    Sequenz

    DLLERQILAA DDVGDASQPD GAGPTDQRNL LRAKEYLEF

    Spezifität

    No cross reactivity with other proteins.

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins.

    Homologie

    different from the related human sequence by eleven amino acids,and from the related rat sequence by one amino acid.

    Produktmerkmale

    Anti-ZBTB7A Antibody. Tested in IHC, WB applications. This antibody reacts with Mouse, Rat.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    A synthetic peptide corresponding to a sequence at the N-terminus of mouse ZBTB7A, different from the related human sequence by eleven amino acids, and from the related rat sequence by one amino acid.

    Isotyp

    IgG
  • Applikationshinweise

    Immunohistochemistry (Paraffin-embedded Section), 0.5-1 μg/mL, Mouse, Rat Western blot, 0.1-0.5 μg/mL, Mouse

    Kommentare

    Antibody can be supported by chemiluminescence kit ABIN921124 in WB, supported by ABIN921231 in IHC(P).

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Konzentration

    500 μg/mL

    Buffer

    Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg Sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    ZBTB7A (Zinc Finger and BTB Domain Containing 7A (ZBTB7A))

    Andere Bezeichnung

    Zbtb7a

    Hintergrund

    Background: Zinc finger and BTB domain-containing protein 7A is a protein that in humans is encoded by the ZBTB7A gene. ZBTB7A has a critical oncosuppressive role in the prostate. Prostate-specific inactivation of ZBTB7A leads to a marked acceleration of PTEN loss-driven prostate tumorigenesis through bypass of PTEN loss-induced cellular senescence. It has been showed that ZBTB7A physically interacts with SOX9 and functionally antagonizes its transcriptional activity on key target genes such as MIA, which is involved in tumor cell invasion, and H19, a long noncoding RNA precursor for an RB-targeting microRNA. Inactivation of ZBTB7A in vivo leads to RB downregulation, bypass of PTEN loss-induced cellular senescence, and invasive prostate cancer. Notably, it has been also found that ZBTB7A is genetically lost, as well as downregulated at both the mRNA and protein levels, in a subset of human advanced prostate cancers. Therefore, ZBTB7A is identified as a context-dependent cancer gene that can act as an oncogene in some contexts but that also has oncosuppressive-like activity in PTEN-null tumors.

    Gene Full Name: zinc finger and BTB domain containing 7a

    Molekulargewicht

    75 kDa

    Gen-ID

    16969

    UniProt

    O88939
Sie sind hier:
Chat with us!